← FDA Drug Approvals (Drugs@FDA)

ZELAPAR

NDA · New Drug Application · Sponsor: BAUSCH · Approved 2006-06-14

Drug application

FDA Application #

NDA021479

Application type

New Drug Application

Brand name

ZELAPAR

Generic name

SELEGILINE HYDROCHLORIDE

Active ingredients

SELEGILINE HYDROCHLORIDE

Dosage form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Marketing status

Prescription

Sponsor

BAUSCH

Manufacturer

Bausch Health US, LLC

First approval

2006-06-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown